BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinomaPharmacogenomics 2017; 18(14): 1343 doi: 10.2217/pgs-2017-0010
2
Sunil Badami, Htay Htay Kyi, Sunil Upadhaya, Samer Al Hadidi. Pancreatic Adenocarcinoma Masquerading as Idiopathic Chronic Pancreatitis with Delayed DiagnosisCase Reports in Oncology 2017; : 819 doi: 10.1159/000480076
3
Zhe-Ying Wang, Xiao-Qing Ding, Hui Zhu, Rui-Xian Wang, Xiao-Rong Pan, Jian-Hua Tong. KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer PatientsFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01295
4
E. A. Dubtsova, L. V. Vinokurova, K. A. Nikolskaya, M. A. Kiryukova, D. S. Bordin. Chronic pancreatitis as a risk factor for pancreatic cancer (a clinical case)Almanac of Clinical Medicine 2018; 46(5): 542 doi: 10.18786/2072-0505-2018-46-5-542-549
5
Shuichi MITSUNAGA, Motohiro KOJIMA, Masafumi IKEDA, Atsushi OCHIAI. Serum microRNAs as tumor markers for diagnosis of pancreatic cancerSuizo 2017; 32(1): 56 doi: 10.2958/suizo.32.56
6
Masaki Kuwatani, Hiroshi Kawakami, Yoshimasa Kubota, Kazumichi Kawakubo, Yoichi M. Ito, Shinji Togo, Takaaki Ikeda, Ken Kusama, Yuka Kobayashi, Teizo Murata, Naoya Sakamoto. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosisPancreatology 2019; 19(4): 569 doi: 10.1016/j.pan.2019.04.007
7
Min Seong Kim, Tae Joo Jeon, Ji Young Park, Jeongmin Choi, Won Chang Shin, Seong Eun Park, Ji-Young Seo, Young Moon Kim. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary DiseaseThe Korean Journal of Gastroenterology 2017; 70(2): 96 doi: 10.4166/kjg.2017.70.2.96
8
Ömer BİNİCİER, Zehra PAKÖZ. Erken akut pankreatitte karbonhidrat antijen 19-9 seviyeleriAkademik Gastroenteroloji Dergisi 2020; : 1 doi: 10.17941/agd.728662
9
Sven H Loosen, Ulf P Neumann, Christian Trautwein, Christoph Roderburg, Tom Luedde. Current and future biomarkers for pancreatic adenocarcinomaTumor Biology 2017; 39(6): 101042831769223 doi: 10.1177/1010428317692231
10
Huimin Zhang, Wei Han, Meng Jin, Yamin Lai, Xi Wang, Jian Wang, Yao Yao, Dong Wu, Jiaming Qian, Hong Yang. Establishment and Verification of a Scoring Model for the Differential Diagnosis of Pancreatic Cancer and Chronic PancreatitisPancreas 2018; 47(4): 459 doi: 10.1097/MPA.0000000000001029
11
Yang Cheng, Kunyuan Wang, Lanlan Geng, Jingjing Sun, Wanfu Xu, Dingli Liu, Sitang Gong, Yun Zhu. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinomaEBioMedicine 2019; 40: 382 doi: 10.1016/j.ebiom.2019.01.003
12
David Sefrioui, France Blanchard, Emmanuel Toure, Paul Basile, Ludivine Beaussire, Claire Dolfus, Anne Perdrix, Marianne Paresy, Michel Antonietti, Isabelle Iwanicki-Caron, Raied Alhameedi, Stephane Lecleire, Alice Gangloff, Lilian Schwarz, Florian Clatot, Jean-Jacques Tuech, Thierry Frébourg, Fabrice Jardin, Jean-Christophe Sabourin, Nasrin Sarafan-Vasseur, Pierre Michel, Frédéric Di Fiore. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumoursBritish Journal of Cancer 2017; 117(7): 1017 doi: 10.1038/bjc.2017.250
13
K. Passek, M. H. Bendels, D. Ohlendorf, E. Wanke, G. M. Oremek, D. A. Groneberg. Der Tumormarker CA 19-9Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2017; 67(6): 327 doi: 10.1007/s40664-017-0211-3
14
Ding-Li Xu, Yi-Qun Wu, Chang Xin, Qi-Feng Zhou, Ming-Liang Chen, Huan-Jun Yan. Simple cholangitis induces extremely and recurrently elevated serum carbohydrate antigen 19-9 levelHepatobiliary & Pancreatic Diseases International 2019; 18(3): 294 doi: 10.1016/j.hbpd.2019.03.008
15
Hunter B. Moore, Rachel Culp-Hill, Julia A. Reisz, Peter J. Lawson, Angela Sauaia, Richard D. Schulick, Marco Del Chiaro, Trevor L. Nydam, Ernest E. Moore, Kirk C. Hansen, Angelo D'Alessandro. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinomaThe American Journal of Surgery 2019; 218(6): 1206 doi: 10.1016/j.amjsurg.2019.08.015
16
Jean-Marc Dumonceau, Myriam Delhaye, Nicolas Charette, Annarita Farina. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1Therapeutic Advances in Gastroenterology 2020; 13: 175628482092729 doi: 10.1177/1756284820927292
17
Haibo Xing, Jing Wang, Yanling Wang, Mengting Tong, Hong Hu, Changxin Huang, Da Li. Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-AnalysisGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/8704751